These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 30680757)

  • 21. Platelet reactivity and mean platelet volume as risk markers of thrombogenesis in atrial fibrillation.
    Makowski M; Smorag I; Makowska J; Bissinger A; Grycewicz T; Paśnik J; Kidawa M; Lubiński A; Zielińska M; Baj Z
    Int J Cardiol; 2017 May; 235():1-5. PubMed ID: 28302320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating microparticles are associated with clinical severity of persistent ST-segment elevation myocardial infarction complicated with cardiogenic shock.
    Sionis A; Suades R; Sans-Roselló J; Sánchez-Martínez M; Crespo J; Padró T; Cubedo J; Ferrero-Gregori A; Vila-Perales M; Duran-Cambra A; Badimon L
    Int J Cardiol; 2018 May; 258():249-256. PubMed ID: 29544939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating Endothelial Cells and Platelet Microparticles in Mitral Valve Disease With and Without Atrial Fibrillation.
    Idriss NK; Blann AD; Sayed DM; Gaber MA; Hassen HA; Kishk YT
    Angiology; 2015 Aug; 66(7):631-7. PubMed ID: 25115553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating annexin V positive microparticles in patients after successful cardiopulmonary resuscitation.
    Fink K; Feldbrügge L; Schwarz M; Bourgeois N; Helbing T; Bode C; Schwab T; Busch HJ
    Crit Care; 2011; 15(5):R251. PubMed ID: 22027379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet activation and induction of tissue factor in acute and chronic atrial fibrillation: involvement of mononuclear cell-platelet interaction.
    Hayashi M; Takeshita K; Inden Y; Ishii H; Cheng XW; Yamamoto K; Murohara T
    Thromb Res; 2011 Dec; 128(6):e113-8. PubMed ID: 21824645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased circulating CD31+/CD42b-EMPs in Perthes disease and inhibit HUVECs angiogenesis via endothelial dysfunction.
    Li B; Huang Q; Lin C; Lu R; Wang T; Chen X; Liu Z; Liu Y; Wu J; Wu Y; Liao S; Ding X
    Life Sci; 2021 Jan; 265():118749. PubMed ID: 33220290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of circulating endothelial and platelet microparticles in men with ankylosing spondylitis.
    Sari I; Bozkaya G; Kirbiyik H; Alacacioglu A; Ates H; Sop G; Can G; Taylan A; Piskin O; Yildiz Y; Akkoc N
    J Rheumatol; 2012 Mar; 39(3):594-9. PubMed ID: 22247348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased phosphatidylserine-exposing microparticles and their originating cells are associated with the coagulation process in patients with IgA nephropathy.
    He Z; Zhang Y; Cao M; Ma R; Meng H; Yao Z; Zhao L; Liu Y; Wu X; Deng R; Dong Z; Bi Y; Kou J; Novakovic V; Shi J; Hao L
    Nephrol Dial Transplant; 2016 May; 31(5):747-59. PubMed ID: 26673909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of remote ischemic preconditioning on electrophysiological and biomolecular parameters in nonvalvular paroxysmal atrial fibrillation (RIPPAF study): Rationale and study design of a randomized, controlled clinical trial.
    Kosiuk J; Milani R; Ueberham L; Uhe T; Stegmann C; Hindricks G; Bollmann A
    Clin Cardiol; 2016 Nov; 39(11):631-635. PubMed ID: 27775830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
    Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
    Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stroke or left atrial thrombus prediction using antithrombin III and mean platelet volume in patients with nonvalvular atrial fibrillation.
    Choi SW; Kim BB; Choi DH; Park G; Shin BC; Song H; Kim D; Kim DM
    Clin Cardiol; 2017 Nov; 40(11):1013-1019. PubMed ID: 28805957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies.
    Niccolai E; Squatrito D; Emmi G; Silvestri E; Emmi L; Ciucciarelli L; Ricci F; Manganaro D; Amedei A; Prisco D
    Thromb Res; 2015 Dec; 136(6):1252-8. PubMed ID: 26476741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphatidylserine-exposing blood cells and microparticles induce procoagulant activity in non-valvular atrial fibrillation.
    Wang L; Bi Y; Yu M; Li T; Tong D; Yang X; Zhang C; Guo L; Wang C; Kou Y; Dong Z; Novakovic VA; Tian Y; Kou J; Shammas MA; Shi J
    Int J Cardiol; 2018 May; 258():138-143. PubMed ID: 29544920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Digoxin use is associated with increased platelet and endothelial cell activation in patients with nonvalvular atrial fibrillation.
    Chirinos JA; Castrellon A; Zambrano JP; Jimenez JJ; Jy W; Horstman LL; Willens HJ; Castellanos A; Myerburg RJ; Ahn YS
    Heart Rhythm; 2005 May; 2(5):525-9. PubMed ID: 15840479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility.
    Takahashi T; Kobayashi S; Fujino N; Suzuki T; Ota C; He M; Yamada M; Suzuki S; Yanai M; Kurosawa S; Yamaya M; Kubo H
    Thorax; 2012 Dec; 67(12):1067-74. PubMed ID: 22843558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced microparticles in ventricular assist device patients predict platelet, leukocyte and endothelial cell activation.
    Diehl P; Aleker M; Helbing T; Sossong V; Beyersdorf F; Olschewski M; Bode C; Moser M
    Interact Cardiovasc Thorac Surg; 2010 Aug; 11(2):133-7. PubMed ID: 20472650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity.
    Chiva-Blanch G; Laake K; Myhre P; Bratseth V; Arnesen H; Solheim S; Badimon L; Seljeflot I
    PLoS One; 2017; 12(2):e0172558. PubMed ID: 28207887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: relationship with oxidative stress.
    Helal O; Defoort C; Robert S; Marin C; Lesavre N; Lopez-Miranda J; Risérus U; Basu S; Lovegrove J; McMonagle J; Roche HM; Dignat-George F; Lairon D
    Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):665-71. PubMed ID: 20399083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flow Cytometric Assessment of Endothelial and Platelet Microparticles in Patients With Atrial Fibrillation Treated With Dabigatran.
    Lenart-Migdalska A; Drabik L; Kaźnica-Wiatr M; Tomkiewicz-Pająk L; Podolec P; Olszowska M
    Clin Appl Thromb Hemost; 2020; 26():1076029620972467. PubMed ID: 33237804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microparticles in atrial fibrillation: a link between cell activation or apoptosis, tissue remodelling and thrombogenicity.
    Jesel L; Abbas M; Toti F; Cohen A; Arentz T; Morel O
    Int J Cardiol; 2013 Sep; 168(2):660-9. PubMed ID: 23623666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.